Al Hayek AA, Robert AA, Al Dawish MA. Differences of FreeStyle Libre Flash Glucose Monitoring System and Finger Pricks on Clinical Characteristics and Glucose Monitoring Satisfactions in Type 1 Diabetes Using Insulin Pump.
CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES 2019;
12:1179551419861102. [PMID:
31308786 PMCID:
PMC6604122 DOI:
10.1177/1179551419861102]
[Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/19/2019] [Accepted: 06/07/2019] [Indexed: 12/15/2022]
Abstract
Background:
To evaluate the different experience of freestyle libre and finger pricks on
clinical characteristics and glucose monitoring satisfaction (GMS) in
patients with type 1 diabetes (T1D) using insulin pump (IP).
Methods:
A prospective study was carried out on 47 (aged 17-21 years) T1D, who used
conventional finger-pricking method for self-testing the glucose. The
experiments were conducted between March 2018 and September 2018. For
carrying out the study, the flash glucose monitoring (FGM) sensors were
placed on each participant, at the baseline visit, by a trained diabetes
educator. Furthermore, to determine the total number of scans conducted
during the study period, the respective ambulatory glucose profiles were
generated by computing the data collected from the sensors. In addition, a
trained interviewer handed over the GMS questionnaire to each patient, at
the baseline and at 12 weeks of the study.
Results:
In comparison to the baseline (finger pricks), various parameters such as:
HbA1c (P = .042), hypoglycemia (P = .001),
mean capillary glucose (P = .004), total daily insulin dose
(P = .0001), percentage of bolus insulin
(P = .0001), daily bolus frequency
(P = .0001), and daily carbohydrates intake
(P = .0001) showed a significant improvement at
12 weeks. Similarly, substantial augmentation was noticed, in the sub
domains of GMS, that is, openness (P = .0001), emotional
burden (P = .0001), behavioral burden
(P = .0001), and trust (P = .0001) at
12 weeks as compared to baseline. Overall, total GMS score at baseline was
1.72 ± 0.37, which increased up to 3.41 ± 0.49 (P = .0001)
in the time period of 12 weeks. The HbA1c (r2 = 0.45),
hypoglycemia (r2 = 0.58), and the mean number of FGM scans,
exhibited a negative correlation, while GMS (r2 = 0.52) and the
mean number of FGM scans, exhibited a positive correlation.
Conclusion:
The frequency of hypoglycemia, HbA1c level, capillary glucose, daily
carbohydrates intake decreased, while the total daily insulin dose, daily
bolus insulin and total GMS score increased with the use of FGM scanning for
12 weeks.
Collapse